Jeff Ehrhardt recently published a column collecting a compendium of citations to recent and trending topics in health law journals for the New York State Bar Association Health Law Journal.

The compendium can be found here.

The journal is available here.

Geoffrey Kaiser will be presenting “Use of the False Claims in Health Care Fraud Investigations and Litigation” at the Upstate New York Health Care Fraud Symposium, hosted by the United States Attorney’s Office For The Northern District of New York.

The event will take place on Friday, September 30, 2022, at Albany Law School, in

Marc Ullman was quoted in the NutraIngredientsUSA article, “Amazon warning over skin tag products puts online giant on notice for assuring regulatory compliance.”

The article explains that the FDA issued a warning letter to Amazon for two marketers whose products are sold on Amazon’s site. These products claim to remove skin tags, but are not

Please join us as Rivkin Radler Associate Ashley Algazi presents the September Lunch and Learn. The program will:

• Review HIPAA breach definition
• Discuss the analysis and investigation process to determine if a breach has occurred
• Review exceptions to the definition of ‘breach’
• Discuss covered entity vs business associate

On July 13, the Office of Medicaid Inspector General (OMIG) published proposed regulations implementing 2020 changes to law relating to provider compliance programs, Medicaid managed care fraud, waste and abuse prevention programs, and OMIG’s self-disclosure program. The proposed changes will significantly impact both payers and providers alike.

Hear from Robert Hussar, a compliance professional and

On September 28, 2022, Jeff Kaiser will be a panelist at the Practising Law Institute’s program, Life Sciences 2022: Navigating Legal Challenges in Drug and Device Industries. The program is designed for attorneys and allied professionals who counsel pharmaceutical and life sciences companies.

Entitled “Enforcement Trends Impacting the Drug and Device Industries,” Jeff’s panel will

Please join us for the June lunch and learn, presented by Partners Frank Izzo and Wendy Sheinberg. The program will discuss:

Article 9 (mental health)
The FHCDA
Article 81 (guardianships)
HIPAA issues

The program will be moderated by Robert Hussar, a partner in Rivkin Radler’s Compliance, Investigations & White Collar and Health

Eric Fader explained that certain steps can be taken in preparation of a medical tourist patient in the PartB News article, “Prepare and monitor: Take extra steps when the patient’s a medical tourist.”

If a patient plans on getting medical treatment in another country, make him or her aware of the risks involved and and

Eric Fader was quoted in the PartB News article, “Did your practice get burned online? Reach out — and redirect.”

The article examines what providers should do when they receive a negative review. Responding can make matters worse or even violate HIPAA.

Even if a patient discloses much of his or her own private health

Marc Ullman commented on the FDA’s recent announcement that it will exercise enforcement discretion on the use of NAC in the NutraIngredientsUSA article, “FDA formally announces NAC enforcement, but legal handover remains.”

The draft guidance came in response to two petitions, one referencing the DSHEA grandfather date of 1994. The FDA rejected the grandfather date